<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02691442</url>
  </required_header>
  <id_info>
    <org_study_id>EC 10/45/315</org_study_id>
    <nct_id>NCT02691442</nct_id>
  </id_info>
  <brief_title>Comparison of the Analgesic Effect of Different Local Anesthetics in Interscalene Nerve Block for Shoulder Surgery</brief_title>
  <official_title>Comparison of the Analgesic Effect of the Local Anesthetics Ropicacaine, Levobupivacaine, and Levobupivacaine + Epinephrin Via Interscalene Nerve Block in Patients Undergoing Shoulder Arthroscopy Under General Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Antwerp</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Antwerp</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Several reports have compared the duration of action of levobupivacaine and ropivacaine as
      local anesthetic. The most widely used method for sensory function evaluation is though means
      of a pinprick test. The investigators want to use the novel method of Quantitative Sensory
      Testing to better evaluate the anesthetic activity. This method used hot and cold sensation
      to assess small nerve fiber function. The investigators will assess the duration of action of
      different drugs when used in an inter scalene nerve block in patients scheduled for shoulder
      surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aims to compare the length of the analgesic effect of different local anesthesic
      solutions, used in an interscalene nerve block. This will be objectified by measuring the
      changes in small nerve functioning, using quantative sensory testing. Based on the results of
      a previous study, the investigators reduce the dose of the administered local anesthetic,
      expecting a similar length of action using these smaller doses.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Length of nerve block measured in longitudinally recorded significant changes in sensory thresholds using quantitative sensory testing</measure>
    <time_frame>24 hours after intervention</time_frame>
    <description>Length of difference in cold and heat pain and sensation measured with quantitative sensory testing</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Need for rescue drugs, as requested by the patient after surgery</measure>
    <time_frame>24 hours after intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor activity block, longitudinally recorded inability to move the blocked limb</measure>
    <time_frame>24 hours after intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensity of nerve block, recorded as maximal changes in sensory thresholds using quantitative sensory testing</measure>
    <time_frame>24 hours after intervention</time_frame>
    <description>The difference in threshold of cold and heat pain and sensation measured with quantitative sensory testing</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Other Peripheral Nerve Disease</condition>
  <arm_group>
    <arm_group_label>Ropivacaine 0.75%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The investigators administer 5 milliliters of Ropivacaine 0.75% in the inter scalene space</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Levobupivacaine 0.5%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The investigators administer 5ml of Levobupivacaine 0.5% in the inter scalene space</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Levobupivacaine 0.5% + epinephrin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The investigators administer 5ml of Levobupivacaine 0.5% + epinephrin 1/200000 in the inter scalene space</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine 0.75%</intervention_name>
    <description>The investigators adminster 5ml of Ropivacaine 0.75% in an ultrasound-guided inter scalene nerve block</description>
    <arm_group_label>Ropivacaine 0.75%</arm_group_label>
    <other_name>Naropin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levobupivacaine 0.5%</intervention_name>
    <description>The investigators adminster 5ml of Levobupivacaine 0.5% in an ultrasound-guided inter scalene nerve block</description>
    <arm_group_label>Levobupivacaine 0.5%</arm_group_label>
    <other_name>Chirocaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levobupivacaine 0.5% + epinephrin 1/200000</intervention_name>
    <description>The investigators adminster 5ml of Levobupivacaine 0.5% + epinephrin 1/200000 in an ultrasound-guided inter scalene nerve block</description>
    <arm_group_label>Levobupivacaine 0.5% + epinephrin</arm_group_label>
    <other_name>Chirocaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesia class I or II

          -  Scheduled for shoulder surgery

        Exclusion Criteria:

          -  Mental retardation

          -  Allergy for local anesthetics

          -  NSAID intolerance or contraindicated

          -  Diabetes mellitus

          -  Chronic use of pain killers
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luc Serieus, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital, Antwerp</affiliation>
  </overall_official>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 1, 2016</study_first_submitted>
  <study_first_submitted_qc>February 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2016</study_first_posted>
  <last_update_submitted>August 11, 2016</last_update_submitted>
  <last_update_submitted_qc>August 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Antwerp</investigator_affiliation>
    <investigator_full_name>Tom Schepens, MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Peripheral nerve block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nervous System Diseases</mesh_term>
    <mesh_term>Peripheral Nervous System Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

